Qualitest Recalls HydrOXYzine Tablets Due to Unreadable Identification Codes
Qualitest Pharmaceuticals is recalling HydrOXYzine Hydrochloride 25 mg tablets because some identification codes are unreadable.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which indicates the product is not likely to cause adverse health consequences. The issue is limited to unreadable identification codes, which is a documentation or labeling defect rather than a direct safety hazard.
Plain-English summary
Qualitest Pharmaceuticals is voluntarily recalling HydrOXYzine Hydrochloride Tablets, USP 25 mg, in 100, 500, and 1000-count bottles. The recall was initiated because the identification codes on some tablets may be unreadable, which could affect the ability to verify the product.
The affected products are distributed nationwide. The recall includes specific lot numbers and expiration dates for the 100-count, 500-count, and 1000-count bottles. The total quantity involved is 47,376 bottles.
Consumers with these products should check their bottles for the specific NDC numbers and lot numbers listed in the recall notice. If the product matches the recalled lots, consumers should contact their pharmacist or Qualitest Pharmaceuticals for instructions on how to return the product or obtain a replacement.
The recalled product
- Product
- HydrOXYzine Hydrochloride Tablets, USP 25 mg, Rx only, 100 count (NDC 0603-3968-21), 500 count (NDC 0603-3968-28) and 1000 count (NDC 0603-3968-32) bottles, Manufactured for Qualitest Pharmaceuticals, Huntsville, AL
- Manufacturer
- Qualitest Pharmaceuticals
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 47,376
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (13)
- 100 count (NDC 0603-3968-21)
- LOTS# T144F13A
- T130G13B
- T132G13A
- exp date 6/15
- T115D14A
- exp date 3/16
- 500 count (NDC 0603-3968-28)
- LOT# T144F13B exp date 6/15
- and 1000 count (NDC 0603-3968-32)
- LOTS # T144F13C
- T132G13B
- T115D14B
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Qualitest Pharmaceuticals
See all →- LowQualitest Recalls Allopurinol Tablets Due to Oversized and Discolored Appearance
FDA (Drugs) · 2015-09-09
- ModerateQualitest Recalls Disulfiram Tablets Due to Dissolution Failure
FDA (Drugs) · 2015-07-08
- LowQualitest Recalls Promethazine VC With Codeine Syrup Due to Impurity
FDA (Drugs) · 2015-04-15
- ModerateQualitest Recalls Promethazine DM Syrup Due to Plastic Particulates
FDA (Drugs) · 2015-03-18
- ModerateQualitest Recalls Amlodipine Besylate Tablets Due to Oversized Size
FDA (Drugs) · 2015-03-11
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02